# Survival Outcomes of Residual Disease in Triple-Negative Breast Cancer

> **NCT07714382** · — · COMPLETED · sponsor: **Sohag University** · enrollment: 100 (actual)

## Conditions studied

- Triple-Negative Breast Cancer (TNBC)

## Interventions

- **PROCEDURE:** Chemo-radiotherapy alone
- **OTHER:** Not applicable- observational study

## Key facts

- **NCT ID:** NCT07714382
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2026-05-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07714382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07714382, "Survival Outcomes of Residual Disease in Triple-Negative Breast Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07714382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*